Open Access

Natural killer cell monitoring in cutaneous melanoma - new dynamic biomarker

  • Authors:
    • Gheorghița Isvoranu
    • Mihaela Surcel
    • Radu-Ionuț Huică
    • Adriana Narcisa Munteanu
    • Ioana Ruxandra Pîrvu
    • Dan Ciotaru
    • Carolina Constantin
    • Ovidiu Bratu
    • Monica Neagu
    • Cornel Ursaciuc
  • View Affiliations

  • Published online on: February 25, 2019     https://doi.org/10.3892/ol.2019.10069
  • Pages: 4197-4206
  • Copyright: © Isvoranu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Melanoma is responsible for most skin cancer deaths in humans. The immune system plays a major role in regulating tumor cell proliferation by initiating defence responses against tumor aggression. Research on murine cancer models allow for a better understanding of immune response in malignancies, revealing specific changes of the immune status in the presence of tumors. Melanoma resistance to conventional therapies and its high immunogenicity justify the development of new therapies. These features reinforce melanoma as a suitable model for studying antitumor immunity. Recent findings on NK cell activation in cancer patients indicate that several important parameters, such as tumor capacity to modulate the function and phenotype of NK cells, require consideration for the choice of an NK-based therapy. In this study, we investigated T-CD4+ and T-CD8+ lymphocytes, B lymphocytes and NK cells in peripheral blood and spleen cells suspension from melanoma-bearing mice compared to healthy controls in order to assess the potential for tumor growth-promoting immunosuppression. Our results indicate that in a melanoma-bearing mouse model the percentage of NK cells in spleen is reduced and that their phenotype is different compared to control mouse NK cells.
View Figures
View References

Related Articles

Journal Cover

May-2019
Volume 17 Issue 5

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Isvoranu G, Surcel M, Huică R, Munteanu AN, Pîrvu IR, Ciotaru D, Constantin C, Bratu O, Neagu M, Ursaciuc C, Ursaciuc C, et al: Natural killer cell monitoring in cutaneous melanoma - new dynamic biomarker. Oncol Lett 17: 4197-4206, 2019.
APA
Isvoranu, G., Surcel, M., Huică, R., Munteanu, A.N., Pîrvu, I.R., Ciotaru, D. ... Ursaciuc, C. (2019). Natural killer cell monitoring in cutaneous melanoma - new dynamic biomarker. Oncology Letters, 17, 4197-4206. https://doi.org/10.3892/ol.2019.10069
MLA
Isvoranu, G., Surcel, M., Huică, R., Munteanu, A. N., Pîrvu, I. R., Ciotaru, D., Constantin, C., Bratu, O., Neagu, M., Ursaciuc, C."Natural killer cell monitoring in cutaneous melanoma - new dynamic biomarker". Oncology Letters 17.5 (2019): 4197-4206.
Chicago
Isvoranu, G., Surcel, M., Huică, R., Munteanu, A. N., Pîrvu, I. R., Ciotaru, D., Constantin, C., Bratu, O., Neagu, M., Ursaciuc, C."Natural killer cell monitoring in cutaneous melanoma - new dynamic biomarker". Oncology Letters 17, no. 5 (2019): 4197-4206. https://doi.org/10.3892/ol.2019.10069